Covalent Modifiers

OCTOBER 12, 2024

Eric M. Merten and John D. Sears and Tina M. Leisner and P. Brian Hardy and Anirban Ghoshal and Mohammad Anwar Hossain and Kesatebrhan Haile Asressu and Peter J. Brown and Edwin G. Tse and Michael A. Stashko and Kelin Li and Jacqueline L. Norris-Drouin and Laura E. Herring and Angie L. Mordant and Thomas S. Webb and Christine A. Mills and Natalie K.

Virus 162

Virus Biochemical Assays FDA Approval FDA 162

Drugs.com

OCTOBER 12, 2024

SATURDAY, Oct. 12, 2024 -- You've broken a hip and rehabilitation is part of the way back to mobility, or your partner has suffered a stroke and needs help re-learning certain skills.These scenarios play out every day for Americans, and.

130

130

New Drug Approvals

OCTOBER 12, 2024

VALILTRAMIPROSATE 1034190-08-3 (S)-3-(2-Amino-3-methylbutanamido)propane-1-sulfonic acid BLU8499 WHO 11912 Molecular Weight 238.30 Formula C 8 H 18 N 2 O 4 S CAS No. 1034190-08-3 ALZ-801 Synonyms: valiltramiprosate, NRM-8499, homotaurine prodrug, 3-APS This is a prodrug of homotaurine, a modified amino acid previously developed under the names tramiprosate and Alzhemed.

Pharmacokinetics 62

Pharmacokinetics Small Molecule Disease Licensing 62

New Drug Approvals

OCTOBER 12, 2024

VICATERTIDE 1251838-01-3 L-Leucyl-L-glutaminyl-L-valyl-L-valyl-L-tyrosyl-L-leucyl-L-histidine C 42 H 66 N 10 O 10 L-Histidine, L-leucyl-L-glutaminyl-L-valyl-L-valyl-L-tyrosyl-L-leucyl- (ACI) 871.04 SB-01, HY-P5542, CS-0887146 (2 S )-2-[[(2 S )-2-[[(2 S )-2-[[(2 S )-2-[[(2 S )-2-[[(2 S )-5-amino-2-[[(2 S )-2-amino-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-(1 H -imidazol-5-yl)propano

62

62

Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials